$VGNT News

RBC Capital Maintains Outperform on Versigent, Raises Price Target to $53

Goldman Sachs Maintains Buy on Versigent, Lowers Price Target to $58

Versigent Announces Third Quarter 2026 Earnings Call Details

Versigent Q2 2026 Earnings Call Transcript

Versigent (VGNT) Price Target Increased by 11.19% to 57.12

Why Versigent (VGNT) Stands to Benefit from Automotive Trends

Versigent (VGNT) Rallies Again With Valuation Still In Focus

Is Versigent (VGNT) Undervalued With Margin Expansion and Buyback Potential Ahead?

Versigent Has Already Run, But I Still See More Upside

Argus Research Maintains Buy on Versigent, Raises Price Target to $54

Evercore ISI Group Maintains Outperform on Versigent, Raises Price Target to $65

Versigent Q2 Earnings Call Highlights

RBC Capital Upgrades Versigent (VGNT)

TD Cowen Maintains Buy on Versigent, Raises Price Target to $58

RBC Capital Upgrades Versigent to Outperform, Raises Price Target to $52

Wells Fargo Maintains Overweight on Versigent, Raises Price Target to $56

Versigent PLC (VGNT) (Q2 2026) Earnings Call Highlights: Record Launches and Dividend ...

Versigent PLC (VGNT) Q2 2026 Earnings Call Transcript

Versigent (NYSE:VGNT) Rises on Q2 Earnings Beat and Raised Full-Year Sales Guidance

Versigent Reports Second Quarter 2026 Results